No Detail Found!

THE IMPROVEMENT IN THE ABI INDEX FOLLOWING 3 MONTH TREATMENT WITH CILOSTAZOL IN PATIENTS WITH MILD TO MODERATE PERIPHERAL ARTERIAL DISEASE

Author(s)
Shams Suleman Department of Pharmacology,Khyber Girls Medical College, Peshawar, Pakistan
M Abid Shah Department of Pharmacology,Khyber Medical College,Peshawar, Pakistan
Abstract
To study the effects of cilostazol in patients with mild to moderate peripheral arterial disease (PAD) using the improvement in ankle brachial pressure index (ABI). Methodology: This hospital based interventionist study was a prospective, open labeled clinical trial. After the baseline data collection cilostazol was given to the group A, while the group B didn't receive cilostazol. The effect of intervention was noted at the timed study points at 4, 6 and 12 weeks .The antiplatelets were used in the group B as a control. Results: The ABI improvement at the end of the study in the cilostazol treated group was marked compared with the control group. The group A had 65 males and 35 females, while the group B had 74 males and 26 females. The total ABI improved in the right and left lower limb with a P value of 0.001 each. The ABI results were better in the male, diabetic and hypertensive subsets of study as compared with female, obese and smoker. Conclusion: Cilostazol significantly improves ABI in PAD. Its use in the indicated population group should be encouraged to improve the management and prevent the complications.
Publication Details
Page(s) 237-246
DOI DOI not available
Published Journal: Journal of Postgraduate Medical Institute, Volume: 28, Issue: 3, Year: 2014

Request the full text from PASTIC

Keywords
atherosclerosis, Peripheral arterial disease, Ankle brachial pressure index, Cilostazol
0

Citations

0

Downloads

38

Views